Specific site involvement in fixed drug eruption - 29/08/11
Abstract |
A total of 105 patients with established fixed drug eruption (FDE) by oral provocation were evaluated with regard to a drug-related site involvement. Cotrimoxazole was the leading causative agent (63.8%), followed by naproxen sodium (23.8%), dipyrone (5.7%), oxicams (4.8%) and other rare causes (1.9%). Cotrimoxazole most frequently induced lesions on genital mucosa; naproxen and oxicams on lips; and dipyrone on trunk and extremities. Isolated FDE on male genitalia (n = 16) was exclusively because of cotrimoxazole. A highly significant association could be established between naproxen and FDE on lips (chi-square = 28.3; corrected P = .000002). As this study represents the largest series of patients with naproxen-induced FDE, we would suggest that naproxen should be considered as an important potential cause of FDE on lips.
Le texte complet de cet article est disponible en PDF.Plan
 | Funding sources: None. Conflicts of interest: None identified. |
Vol 49 - N° 6
P. 1003-1007 - décembre 2003 Retour au numéro
Article précédent
- CME examination : Identification no. 803-112.instructions for category i cme credit appear in the front advertising section. see last page of contents for page number
- Anetoderma and its prothrombotic abnormalities
- Agnes Sparsa, Jean Charles Piette, Bertrand Wechsler, Zahir Amoura, Camille Francès
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?